ONO-7913 Phase I Study (ONO-7913)

NCT04403308 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

BIOLOGICAL: ONO-7913

Sponsor

Ono Pharmaceutical Co., Ltd.